AlzeCure Pharma AB
Share:
Subscribe:
news.cision.com
/
AlzeCure Pharma AB
/
AlzeCure changes direction for its drug candidate ACD855 within the NeuroRestore platform
/
alzecure
alzecure
Fri, May 03, 2019 20:00 CET
Low resolution
Medium resolution
Original resolution
Subscribe
Related Releases
AlzeCure Pharma today presented key preclinical data on its novel cognitive enhancer at the AAT-AD/PD conference
Thu, Apr 02, 2020 17:30 CET
Report from the annual general meeting of AlzeCure Pharma on 22 May 2019
Wed, May 22, 2019 17:30 CET
AlzeCure publishes its Annual Report for 2018
Mon, Apr 15, 2019 17:45 CET
